Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor

Richard Rozmahel, Michael Wilschanski, Angabin Matin, Suzanne Plyte, Mary Oliver, Wojtek Auerbach, Aideen Moore, Janet Forstner, Peter Durie, Joseph Nadeau, Christine Bear, Lap Chee Tsui

Research output: Contribution to journalArticlepeer-review

366 Scopus citations

Abstract

Mice that have been made deficient for the cystic fibrosis transmembrane conductance regulator (Cftr) usually die of intestinal obstruction. We have created Cftr-deficient mice and demonstrate prolonged survival among backcross and intercross progeny with different inbred strains, suggesting that modulation of disease severity is genetically determined. A genome scan showed that the major modifier locus maps near the centromere of mouse chromosome 7. Electrophysiological studies on mice with prolonged survival show that the partial rectification of Cl- and Na+ ion transport abnormalities can be explained in part by up-regulation of a calcium- activated Cl- conductance. Identification of modifier genes in our Cftr(m1HSC)/Cftr(m1HSC) mice should provide important insight into the heterogeneous disease presentation observed among CF patients.

Original languageEnglish (US)
Pages (from-to)280-287
Number of pages8
JournalNature Genetics
Volume12
Issue number3
DOIs
StatePublished - Mar 1996

ASJC Scopus subject areas

  • Genetics

Fingerprint

Dive into the research topics of 'Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor'. Together they form a unique fingerprint.

Cite this